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[Abstract] Mice are widely used for human tumor xenograft studies of cancer development 
and drug efficacy and toxicity. Stable isotope tracing coupled with metabolomic analysis is an 
emerging approach for assaying metabolic network activity. In mouse models there are 
several routes of tracer introduction, which have particular advantages and disadvantages that 
depend on the model and the questions addressed. This protocol describes the bolus i.v. route 
via repeated tail vein injections of solutions of stable isotope enriched tracers including 
13C6-glucose and 13C5,15N2-glutamine. Repeated injections give higher enrichments and over 
longer labeling periods than a single bolus. Multiple injections of glutamine are necessary to 
achieve adequate enrichment in engrafted tumors. 
 
Materials and Reagents 
 
1. 0.5 ml K2-EDTA collection tubes (BD, catalog number: 363706) 
2. Sterile syringes and gauge 30 needles (Thermo Fisher Scientific, catalog number: 
10142534) 
3. 5-inch squares Al foil 
4. Indelible marker pens (black)-Sharpie fine tip 
5. Pasteur pipet 
6. Lancets (MEDIpoint, Inc., model: Goldenrod 5 mm) 
7. Mice bearing tumor xenograft 
Note:The strain of immunocompromised recipient mouse depends on type of implant. 
Young NOD/SCID Gamma (NSG) mice are especially favorable for the patient derived 
xenograft (PDX) model. 
8. Ketamine for anesthesia if needed, Schedule III controlled substance (Sigma-Aldrich, 
catalog number: K2753) 
9. Tracer [e.g. 13C6-glucose, 13C2-1, 2-glucose (60 mg/mouse), or 13C5, 15N2-glutamine 
(22 mg/mouse)] 
10. Sources 
a. D-Glucose-13C6 (Cambridge Isotope Laboratories, Inc., catalog number: 
CLM-1396-CTM) 
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b. D-Glucose-1, 2-13C2 (Cambridge Isotope Laboratories, Inc., catalog number: 
CLM-504) 
c. L-Glutamine-13C5, 15N2 (Cambridge Isotope Laboratories, Inc., catalog number: 
CNLM-1275) 
Or 
d. D-Glucose-13C6 (Sigma-Aldrich, catalog number: 660663) 
e. D-Glucose-1, 2-13C2 (Sigma-Aldrich, catalog number: 661422) 
f.   L-Glutamine-13C5, 15N2 (Sigma-Aldrich, catalog number: 607983)  
11. Liquid nitrogen 
12. 70% ethanol 
13. 10% Neutral buffered formalin (Thermo Fisher Scientific, ProtocolTM, catalog number: 
032-059) 
14. 25% w/v sterile filtered (0.2 µm) 13C glucose in PBS 
Note: Stock solution-can be frozen and stored at -25 °C.  
15. Sterile wipes (Uline, catalog number: S-16183) 
16. Sodium Chloride (NaCl) (Thermo Fisher Scientific, catalog number: S271-1) 
17. Potassium chloride (KCl) (Sigma-Aldrich, catalog number: P9541) 
18. Sodium phosphate dibasic (Na2HPO4) anhydrous (Sigma-Aldrich, catalog number: 
S-0876) 
19. Potassium phosphate monobasic (KH2PO4) anhydrous (Sigma-Aldrich, catalog 
number: P9791) 
20. 10x Phosphate Buffered Saline (PBS) (see Recipes)  
21. Stock solution for 0.2% 13C6-glucose (see Recipes)  
22. Stock solution for 13C5, 15N2-Gln (10 ml) (see Recipes) 
 
Equipment 
 
1. Mouse restraining system (Plas-Labs, Inc., model: 541-RR) 
2. FirstHand Surgical Instrument Kits for Mice and Rats (Kent Scientific Corporation, 
model: INSMOUSEKIT) 
3. Blue wax dissection tray (VWR International, catalog number: 10060-188) 
4. Warming blanket (Kent Scientific Corporation, model: DCT-15) 
5. Water bottle with DI water (Thermo Fisher Scientific, catalog number: 02-897-11) 
6. Polystyrene Weigh boats (USA Scientific Inc., catalog number: 2347-1427) 
7. Calipers for measuring tumor size (Thermo Fisher Scientific, catalog number: 
15-077-957) 
8. 2-place Balance for weighing tissues (VWR International, Adventurer Ohaus®, catalog 
number: 10153-744) 
9. Refrigerated Microfuge (Eppendorf, model: 5417R with rotor) 
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10. Dewar/bucket (Nalgene plastic dewar) for lN2 (Thermo Fisher Scientific, catalog 
number: S34074C) 
11. Large Styrofoam box 
 
Procedure 
 
All experiments must be performed under an IACUC approved protocol. For human tissue 
xenografts, the appropriate IRB approvals must also be met. 
A. Schedule 
1. Allow tumor in mice to develop to at least 0.5 cm and up to 1.5 cm according to 
specific protocols for ectopic or orthotopic xenografts of cells or fresh tissue (PDX 
model) as well as other tumor models (e.g. transgenic tumor model). 
2. Preparations 
Day before Stable Isotope Resolved Metabolomics (SIRM) experiment: 
a. Pre-label Al squares with date, mouse number and tissue (e.g. tumor), and blood 
collection tubes (2 per mouse for collection immediately after tracer injection, and 
at the time of necropsy) with date, mouse number, collection time. 
b. Label storage box for -80 °C freezer. 
c. Prepare tracer solutions e.g. 25% 13C6-glucose (1.344 M) or 36.2 mg/ml 13C5, 
15N2-Gln (0.2 M) in sterile PBS, sterile filter, and store in aliquots at < -20 °C.   
d. Label formalin bottles with date, mouse number and tumor source. 
e. Assemble all components in sealable boxes for transport. 
f.  Prepare schedule sheet (see example below, Table 1). 
3. Tracer Injection 
When mice are ready, restrain the mouse in the mouse restrainer, sterilize the 
injection area of the tail vein using a sterile wipe. Inject stable isotope tracers through 
the tail vein (or other convenient vein, such as submandibular vein) into individual 
immobilized mice*. Placing the mouse on a warming blanket or gently heating the tail 
visibly dilates the vein to make injection easier.   
a. Record time of injection. 
b. Immediately take blood sample (see step 5 below). 
c. For 13C6-glucose (can be purchased from Sigma Isotec or Cambridge Isotopes 
Laboratories, see above): Inject 80 µl (20 mg) each 25% (w/v) stock solution (in 
3 times (total = 322 µmol).  
d. For 13C5, 15N2-Gln: Same as above except for injecting 200 µl (7.2 mg) each 36.2 
mg/ml stock solution (in PBS and 0.2 µm sterile filtered) at 15 min intervals 3 times 
(total = 142 µmol). 
e. The bolus injections take a few seconds. The extremely high heart rate of mice 
(500-600 beats per minute for resting adult mice) ensures that the tracer is 
systemically distributed very rapidly, therefore approximating a pulse. 
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Note: *We have tried injection into ketamine-anesthetized mice. Since anesthesia 
slows metabolism, the timing has to be lengthened. Anesthesia can also alter 
metabolism. With the physical restraint method, it is important to minimize stress 
to the restrained mice during injection. Black mice are more difficult to inject via tail 
vein. The ability to do timed injections reproducibly takes considerable practice.  
4. Tissue harvest 
a. At 45 min after the first injection (15 min after the last injection), take photographs 
of the mouse and the tumor. 
b. Take blood sample before killing mice by cervical dislocation (do not use CO2 
asphyxiation or lethal injection of barbiturates as they interfere with metabolism)  
c. Measure tumor size using calipers (Figure 1). 
d. Dissect relevant tissues, e.g. tumor, lung, liver, heart, kidney, brain, skeletal 
muscle, adipose, lower bowel and flash freeze tissues immediately (within 5 min of 
necropsy) in liquid N2, followed by placing frozen tissues in screw-cap 2 ml 
microfuge tubes pre-equilibrated in liquid N2 or in aluminum foil (made into a boat 
shape) floating on liquid N2, followed by wrapping**. 
      Note: **Use non-erasable (solvent-resistant) permanent ink Sharpie pens to label       
      sample tubes or aluminum foil to avoid label washout. 
 
e. The order of dissection is dictated mainly by the major organ of interest, which 
should be removed first if possible. Dissected tissue is rinsed briefly in cold PBS, 
blotted and flash-frozen in liquid N2 within 2-6 min of euthanasia. 
f.  Tumor should be rinsed in cold PBS, blotted and weighed before flash freezing in 
lN2 (Figure 1) and photographed. 
g. Typically at least three people are needed for this work. 
h. With multiple injections, it is practical to do three mice as a group, timing injections 
5 min apart.  
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Figure 1. Mouse necropsy. A. NSG mouse with implanted tumors. Measuring size using 
electronic calipers; B. Dissection to reveal ectopic tumor. Blood tubes in orange rack; C. 
Tumor pieces being weighed after blotting. 
 
5. Blood sample processing  
a. Blood should be collected***immediately into K2-EDTA microtubes [‘purple top”] 
(designed for mice) after tracer injection (1st) and just prior to necropsy (2nd).  
b. Initial blood collection should be no more than 150 µl; collect as much blood as 
possible for the 2nd collection.  
c. Let blood stand at room temperature for 5 min before storage on ice****.  
d. Centrifuge blood at 3,500 x g for 15 min at 4 °C.  
e. Separate plasma from blood cells and flash freeze the separated components in 
liquid N2. 
Notes: 
1. EDTA anticoagulant is preferred over citrate, heparin etc. as EDTA interferes least 
with metabolism 
2. ***We collect blood intraorbitally or via the submandibular vein using a lancet which is 
generally preferred (Golde et al., 2005); other methods may be applicable (e.g. from 
other vein) and at sacrifice, cardiac punch for maximal blood collection. 
3. ****It is important to keep blood at RT for 5 min to reduce hemolysis but store blood on 
ice thereafter until centrifugation. 
4. All samples are stored at -80 °C or colder. 
5. If necessary, samples for analysis should be shipped overnight on dry ice. 
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6. Metabolites are extracted from tissues and blood according to established protocols, 
and then analyzed by high resolution NMR, GC-MS, and FT-ICR-MS to establish not 
only the content of metabolites, but also their labeled isotopomer and isotopologue 
distributions, which represents metabolic transformation from the source tracer to the 
observed metabolites in the interval between injection and necropsy (Fan et al., 2011; 
Fan, 2012a; Fan et al., 2012; Lane et al., 2011). 
 
Representative data 
 
Qualitatively similar 13C metabolite profiles of individual organs have been obtained from 
these experiments at comparable time points, as estimated from 1-D 1H{13C}-HSQC 
spectra (e.g. Figure 2) (Fan et al., 2011; Yuneva et al., 2012; Sellers et al., 2015; Xie et al., 
2014). The amounts of 13C in each metabolite per mg can be calculated from the intensity 
of the lactate methyl resonance compared with its concentration independently determined 
by either 1H NMR or GC-MS. These methods also provide the fractional enrichments of 
each observable metabolite, as described in Lane et al. (2008). Detailed descriptions of 
data reduction and analysis are provided in Fan et al. (2011) and Lane et al. (2008). 
 
 
Figure 2. 1D 1H{13C} HSQC spectra of different organs of an NSG mouse infused 
with 13C6-glucose. The NSG mouse received three boluses of 20 mg each 13C6-glucose 
via tail vein injection at 15 min interval. Heart, kidney, liver, brain and lung tissues were 
dissected within 5 min of necropsy, flash-frozen in liq. N2, pulverized in liq. N2, and 
extracted with acetonitrile: H2O: CHCl3 (4:3:2 v/v) for polar metabolites as described in 
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(10). The NMR spectra were normalized to the residual dry residual weight of the extract. 
Extracts are lyophilized prior to preparation of the NMR sample, as described (Fan, 2012b). 
 
Table 1. Example record sheet  
Title: 
Date:  
Experiment: Tumor from patient # (Date) implanted into 2 NSG mice (name of researcher). 
2 mice, each piece subQ implanted on both flanks 
mouse 1 F  tumor sizes=                       ear tag #  
mouse 2 M  tumor sizes=                       ear tag #    
SIRM/harvesting Date 
Treatment: 3 x 80 µl 25% 13C6-glucose tail vein 15 min intervals (M1) or 3 x 200 µl, 36 
mg/ml 13C5, 15N2-Gln (M2).    
Anesthetic Y/N. 
Organs extracted sequentially: 
Blood, tumor, lung, heart, liver, kidney, brain… 
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Put sample into formalin for pathology. Place small samples into medium for further 
propagation in NSG mice and for cell culturing. 
 
Notes 
 
1. The injections can be achieved with restraints, which is compromised by release of 
stress hormones. Alternatively the mice can be anesthetized with ketamine, which can 
slow general metabolism while they are unconscious and alter certain metabolic 
pathway(s) due to the non-intended effect of the anesthetic agent.   
Time Process Time post injection / min comments 
M1          80 µl Glc 0  
     Blood   
     80 µl Glc   
 80 µl Glc   
    blood   
   sac   
   Tumor       Mass:                     
g 
  Lung    
  Heart   
   Liver   
   kidney   
 brain   
     
M2         200 µl Gln 0  
  Blood   
    200 µl Gln   
    200 µl Gln   
 blood   
   sac   
   Tumor     Mass:                       
g 
  Lung   
 Heart   
 Liver   
   kidney   
  brain   
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2. Tail vein injection of black mice can be challenging. Alternatives are intraperitoneal 
injection (which has a different time course), feeding or direct infusion via the jugular 
vein or carotid artery (de Graaf et al., 2011) 
(http://jaxmice.jax.org/preconditioned/surgical/pricing.html).  
3. For xenografts a variety of immune compromised strains are available, which can be 
used according to the study design (http://jaxmice.jax.org/findmice/index.html). 
Xenografts can be formed after injection of established cancer cells (Fan et al., 2011; 
Lane et al., 2011), primary cell lines, and fresh tumor tissue (PDX model) (Sellers et al., 
2015) either subcutaneously or orthotopically. The amounts tissue needed and the 
number of cells depends greatly on the source of the tumor or cell line characteristics. 
4. Blood analysis is crucial to monitoring the amount of tracer delivered and the overall 
utilization over the period of the experiment. The transient nature of the experiments 
provides both information about pathways that are operative during the short labeling 
time period and the relative rates of uptake and utilization of different tissues. This can 
be refined by time course analysis of a group of mice harvested at different times post 
injection. Different numbers of injections also can be used to extend or decrease the 
degree of labeling in different groups of metabolites. Examples of blood metabolite time 
courses in mice injected with 13C-glucose are in Fan et al. (2011).  
5. With bolus injections isotopic steady state cannot be reached (de Graaf et al., 2011; 
Maher et al., 2012), and metabolites with slow turnover do not become significantly 
labeled. For labeling these metabolites, continuous infusion via an appropriate vein for 
a longer period (Marin-Valencia et al., 2012) or longer-term tracer feeding can be 
employed.  
6. Due to some variability of mice age, handling, and tumor status, it may not be practical 
to average metabolite values from different individuals. 5 or more mice/group are 
needed depending on the effect size. Preferably all the same gender should be used, 
and whenever possible littermates. With PDX models we usually match the mouse 
gender to that of the tumor donor. 
 
Recipes 
  
1. 10x PBS 
80 g NaCl  
2 g KCl  
14.4 g Na2HPO4 anhydrous  
2.4 g KH2PO4 anhydrous  
Dissolve in 950 ml 18 MOhm water, pH to 7.4, make to 1 L, sterile filter (0.2 µm) 
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2. Stock solution for 13C6-glucose (10 ml) 
2.5 g 13C6-glucose  
1x PBS to a total of 10 ml 
Sterile filter (0.2 mm) into sterile screw cap container 
Stored at -4 °C 
3. Stock solution for 13C5, 15N2-Gln (10 ml) 
0.362 g 13C5, 15N2-Gln   
1x PBS to a total of 10 ml 
Sterile filter (0.2 mm) 1 ml aliquots into sterile screw cap vials 
Stored at -80 °C 
Note: Glutamine stock should be made fresh or stored at -20 °C in small aliquots to avoid 
repeated freezing and thawing. It forms pyroglutamate on storage in solution at neutral pH 
at higher temperatures.  
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